1-1 of 1
Anne Mette Buhl, Ph.D.
Close
Sort by
Journal Articles

CLLU1, a Novel Molecular Marker for Minimal Residual Disease Monitoring in Chronic Lymphocytic Leukemia

Danelle James, M.D., Esther D Avery, Laura Rassenti, Ph.D., Thomas J. Kipps, M.D., Ph.D., Anne Mette Buhl, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3158.
https://doi.org/10.1182/blood.V112.11.3158.3158
Published: 2008